RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.

Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.

Add to Collection
2020 Nov Systematic Review and Meta Analysis Fist_Author_Year_PM

Full Author : ['Home, Philip D', 'Aroda, Vanita R', 'Blonde, Lawrence', 'Guyot, Patricia', 'Shaunik, Alka', 'Fazeli, Mir Sohail', 'Goswami, Hardik', 'Kalra, Sanjay', 'Pourrahmat, Mir-Masoud']
Journal Title : Diabetes, obesity & metabolism
Chapter : Section3
Journal Year : 2020
Cited by : Not Available

AIMS: To estimate the relative treatment effect between the fixed-ratio combinations iGlarLixi and IDegLira (glucagon-like peptide 1 receptor agonist with basal insulin) in people with type 2 diabetes inadequately controlled on a glucagon-like peptide 1 r.....

Keywords : ["type diabetes inadequately control", "systematic literature review", "indirect treatment comparison", "iglarlixi versus ideglira", "glucagonlike receptor agonist", "safety", "efficacy", "adult"]